Holen Sie sich die Stockscreener-App
7.44
8.30%
0.57
Handel nachbörslich:
7.42
-0.02
-0.27%
Schlusskurs vom Vortag:
$6.87
Offen:
$6.98
24-Stunden-Volumen:
8.28M
Relative Volume:
1.21
Marktkapitalisierung:
$1.31B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.2894
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
+6.44%
1M Leistung:
-10.58%
6M Leistung:
-44.93%
1J Leistung:
+6.74%
1-Tages-Spanne:
$6.9504
$7.49
1-Wochen-Bereich:
$6.755
$7.49
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.44 | 1.21B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Global Digital Therapeutics Market Experiencing Rapid Growth at a CAGR of ~28% by 2032 Amid Rising Demand for Personalized Healthcare| DelveInsight - The Malaysian Reserve
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - TradingView
2 Stocks Down More Than 90% That Still Aren't Worth Buying - AOL.com
Teladoc Health Inc. Hits Oversold Level on RSI IndicatorReal Time Alerts Based on AI Prediction Triggered - 선데이타임즈
Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care| DelveInsight - PR Newswire UK
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - Yahoo Finance
Teladoc's Strategic Shift: Can Integrated Care and Insurance-Driven Mental Health Restore Growth? - AInvest
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
TDOC Q2 Deep Dive: Insurance Transition and Product Expansion Shape Outlook - ca.finance.yahoo.com
5 Must-Read Analyst Questions From Teladoc’s Q2 Earnings Call - FinancialContent
Global and U.S. AI-powered Telemedicine Market Exclusive - openPR.com
Price Channel Expanding on Teladoc Health Inc.’s ChartBuy Low Sell High Stock Watch Strategy in Focus - metal.it
Teladoc (TDOC) Q2 Revenue Tops Estimates - AOL.com
Teladoc Health, Inc. shares fall 1.65% intraday as healthcare sector faces broad challenges. - AInvest
Telemedicine Technologies Market Size Growth Trends Report 2035 - MarketReports.us
Revolutionizing Success in the Combined Telehealth - openPR.com
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Amwell's Strategic Reinvention: Can Narrowing EBITDA Losses and Subscription Growth Fuel Long-Term Value in the Mental Health Tech Sector? - AInvest
Unexpected Trends Reshaping the U.S. Telemedicine Market - openPR.com
How the U.S. Telehealth Market Will Evolve by 2032Growth, - openPR.com
Global Telemedicine Market: Unxpected Growth in Digital Healthcare Delivery & Remote Care | 2025-2032 - openPR.com
Global Telehealth Market: Evolving Patient-Centric Platforms Driving Healthcare Transformation | 2025-2032 - openPR.com
Does Teladoc Health Inc. stock perform well during market downturnsHarness the power of proven investment plans - Jammu Links News
What are the technical indicators suggesting about Teladoc Health Inc.Build wealth faster with consistent investment plans - Jammu Links News
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses - MSN
How strong is Teladoc Health Inc. company’s balance sheetOutstanding capital appreciation - Jammu Links News
What is Teladoc Health Inc. company’s growth strategyGet exclusive market insights for better trading - Jammu Links News
What are the latest earnings results for Teladoc Health Inc.Skyrocketing investment returns - Jammu Links News
How volatile is Teladoc Health Inc. stock compared to the marketAchieve rapid portfolio appreciation today - Jammu Links News
Should I hold or sell Teladoc Health Inc. stock in 2025Capitalize on emerging growth stocks - Jammu Links News
How does Teladoc Health Inc. generate profit in a changing economyCapitalize on stocks with high profit margins - Jammu Links News
What makes Teladoc Health Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News
Is Teladoc Health Inc. a growth stock or a value stockMaximize gains with strategic stock entries - Jammu Links News
When is Teladoc Health Inc. stock expected to show significant growthFree Wealth Planning Blueprint - Jammu Links News
What analysts say about Teladoc Health Inc. stockUncover the best stocks for explosive growth - Jammu Links News
What drives Teladoc Health Inc. stock priceMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Teladoc Health Inc. stock higher in 2025Massive portfolio appreciation - Jammu Links News
Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures. - AInvest
Mixed Analyst Opinions on Healthcare Stocks: Teladoc, Ionis Pharmaceuticals, and Repligen - AInvest
Digital Health Market Set to Witness Significant Growth by 2025-2032 | Teladoc Health, American Well Corporation - openPR.com
Upcoming Opportunities in Pediatric Telehealth Visits Market: - openPR.com
Telehealth Heats Up With Teladoc, Livongo Health $18B Merger - PYMNTS.com
Teladoc Health rises on results beat, guidance announcement - MSN
Teladoc beats Wall Street expectations in Q2 amid strategic revamp - Healthcare Dive
Is it the right time to buy Teladoc Health Inc. stockFinancial News Report For Fast Growth - Jammu Links News
Teladoc Health, Inc. (NYSE:TDOC) Q2 2025 Earnings Call Transcript - Insider Monkey
The Teladoc Health, Inc. (NYSE:TDOC) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Analysts Have Made A Financial Statement On Teladoc Health, Inc.'s (NYSE:TDOC) Second-Quarter Report - Yahoo Finance
Teladoc Health likely to post a Q2 loss and year-over-year decline in revenue - MSN
Teladoc Health Inc. stock chart pattern explainedLong Hold Safe Return Strategy Reviewed - metal.it
Teladoc Inc. Earnings Call: Growth Amid Challenges - MSN
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):